Leading health insurers such as UnitedHealthcare, WellPoint, and Humana have retained CRA to assess the competitive effects of mergers and present our findings to federal and state regulators. Our experts have analyzed the product and geographic markets for commercial and government-sponsored health plans, the likelihood that buy-side market power could be exercised, the competitive constraints of entry and expansion, and the effect of regulations and oversight on plan pricing and quality.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...